Dechra Pharmaceuticals PLC — Remuneration Information 2018

Oct 26, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3606F

Dechra Pharmaceuticals PLC

26 October 2018

26 October 2018

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

The Company announces that on 26 October 2018 the following Directors were granted awards over Ordinary Shares of 1 pence each in the Company under the Dechra 2017 Long Term Incentive:

Name of individual	Director	Type of award	Number of shares subject to award
Ian Page	Director	LTIP Award - nil cost option	46,168
Richard Cotton	Director	LTIP Award - nil cost option	25,589
Tony Griffin	Director	LTIP Award - conditional award	14,444

The vesting of all the above awards is subject to the achievement of performance targets. In respect of these grants the performance conditions will be determined by reference to the Company's Earnings per Share (EPS) and its Total Shareholder Return (TSR) relative to constituent companies of the FTSE 250 index (excluding investment trusts) over a three year performance period. Both the EPS and TSR elements will be subject to an additional Return on Capital Employed (ROCE) performance condition. If the ROCE performance condition is not met, then the LTIP Awards will lapse in full.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Ian Page

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 1 pence each

ISIN: GB0009633180

b)

Nature of the transaction

Grant of an award over Ordinary Shares under the Company's Long Term Incentive Plan

c)

Price(s) and volumes(s)

Nil cost option

Price	Volume
Nil cost award	46,168

d)

Aggregated information

-   Aggregate volume

-   Price

Awards granted over 46,168 Ordinary Shares in total

N/A

e)

Date of the transaction

2018-10-26

f)

Place of the transaction

Outside a trading venue

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Richard Cotton

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 1 pence each

ISIN: GB0009633180

b)

Nature of the transaction

Grant of an award over Ordinary Shares under the Company's Long Term Incentive Plan

c)

Price(s) and volumes(s)

LTIP Award

Price	Volume
Nil cost award	25,589

d)

Aggregated information

-   Aggregate volume

-   Price

Awards granted over 25,589 Ordinary Shares in total

N/A

e)

Date of the transaction

2018-10-26

f)

Place of the transaction

Outside a trading venue

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Tony Griffin

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 1 pence each

ISIN: GB0009633180

b)

Nature of the transaction

Grant of an award over Ordinary Shares under the Company's Long Term Incentive Plan

c)

Price(s) and volumes(s)

Conditional award

Price	Volume
Nil cost award	14,444

d)

Aggregated information

-   Aggregate volume

-   Price

Awards granted over 14,444 Ordinary Shares in total

N/A

e)

Date of the transaction

2018-10-26

f)

Place of the transaction

Outside a trading venue

For further information, please contact:

Melanie Hall, Company Secretary                 

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFKADDNBDDOKB